genprowebdirectory
GEN Edge
Featured News
Multimedia
News
Insights
Trends for 2020
Trends for 2021
Trends for 2023
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
GEN Edge
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Videos
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Cancer
How Incurable Melanoma Resists Treatment
AgBio
Food For Thought: Final Report from the AGBT Ag Meeting
Cancer
Molecular Time Travel Helps Colon Cells Turn Cancerous
Autism
Amino Acid Deficit Impacts Perinatal Mouse Brain Development, Leading to Microcephaly,…
Drug Delivery
Nature’s Needle: Feng Zhang’s Team Re-engineers Bacterial “Syringes” for Programmable Protein…
Insights
All
Trends for 2020
Trends for 2021
Trends for 2023
Base Editing
One-Time Treatment: Base Editing Shows Promise vs. SMA
Drug Delivery
Nature’s Needle: Feng Zhang’s Team Re-engineers Bacterial “Syringes” for Programmable Protein…
Bioprocessing
Polymer Formulation to Improve Existing Antibiotics
Bioprocessing
Key Consideration for Going Digital
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
GEN Edge
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Drug Discovery
Seven Biopharma Trends to Watch in 2023
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Videos
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
Antibodies
Antibody Drug Conjugates
Page 12
Antibody Drug Conjugates
Antibody Drug Conjugates
Bispecific Antibodies
Epitope Mapping
Monoclonal Antibodies
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Antibody Drug Conjugates
StockWatch: Antitrust Fears Dampen Support for $43B Pfizer-Seagen Deal
Drug Discovery
StockWatch: Pfizer Scales Patent Cliff by Pursuing Seagen Deal
Biogen
StockWatch: Biogen’s New CEO Takes Slow Approach to New Cost Cuts
Antibody Drug Conjugates
Lonza Collaborates with Cristal Therapeutics and McSAF to Expand Bioconjugates Offering
Antibody Drug Conjugates
Catalent to Establish a New Bioanalytical Center of Excellence
Antibody Drug Conjugates
Genmab Taps into Seattle’s ADC Technology to Develop Anticancer HuMax-TF Conjugate
Antibody Drug Conjugates
Disappointing Phase II Data Leads Seattle to Ditch AML Candidate
Antibody Drug Conjugates
Seattle Genetics Gains $12M from Genentech with Expanded ADC Partnership
Antibody Drug Conjugates
Seattle Genetics Receives $12M Up Front in Deal with GSK
Antibody Drug Conjugates
Millennium Gains Seattle’s Late-Stage Lymphoma Drug with Initial $60M Fee
Antibody Drug Conjugates
Genentech Ends Collaboration with Seattle Genetics for Phase I Anticancer mAb
Antibody Drug Conjugates
Amgen to Apply ImmunoGen TAP Technology to Another Cancer Target
Antibody Drug Conjugates
Medarex Taps Lonza for Biomanufacturing
Antibody Drug Conjugates
Innova Licenses Antibodies to Develop Cancer Research Tools
Antibody Drug Conjugates
Millennium Taps Seattle Genetics for Antibody-Drug Conjugate Development with $4M Up...
1
...
10
11
12
Page 12 of 12
Scroll Up
![Firm will now focus on pivotal Hodgkin lymphoma ADC and earlier clinical pipeline. [© GodMaker - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/Sept13_2010_22822004_OldLadywCat_SeatlleDitchesAMLCandidate6126023610-324x160.jpg "Disappointing Phase II Data Leads Seattle to Ditch AML Candidate")